134 related articles for article (PubMed ID: 32542526)
1. Change over time in ability to perform activities of daily living in myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
J Neurol; 2020 Nov; 267(11):3235-3242. PubMed ID: 32542526
[TBL] [Abstract][Full Text] [Related]
2. Activities of daily living in myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
Acta Neurol Scand; 2020 May; 141(5):380-387. PubMed ID: 31889295
[TBL] [Abstract][Full Text] [Related]
3. How to capture activities of daily living in myotonic dystrophy type 2?
Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
[TBL] [Abstract][Full Text] [Related]
4. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
Symonds T; Randall JA; Campbell P
Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
[TBL] [Abstract][Full Text] [Related]
5. Disease burden of myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Gorman G; Turner C; Lochmüller H
J Neurol; 2019 Apr; 266(4):998-1006. PubMed ID: 30788616
[TBL] [Abstract][Full Text] [Related]
6. Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1.
Raymond K; Levasseur M; Mathieu J; Gagnon C
Arch Phys Med Rehabil; 2019 Sep; 100(9):1629-1639. PubMed ID: 30831092
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy.
van As D; Okkersen K; Bassez G; Schoser B; Lochmüller H; Glennon JC; Knoop H; van Engelen BGM; 't Hoen PAC;
J Neuromuscul Dis; 2021; 8(6):1031-1046. PubMed ID: 34250945
[TBL] [Abstract][Full Text] [Related]
8. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
van Engelen B;
Trials; 2015 May; 16():224. PubMed ID: 26002596
[TBL] [Abstract][Full Text] [Related]
9. Body composition and clinical outcome measures in patients with myotonic dystrophy type 1.
Sedehizadeh S; Brook JD; Maddison P
Neuromuscul Disord; 2017 Mar; 27(3):286-289. PubMed ID: 28082208
[TBL] [Abstract][Full Text] [Related]
10. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).
Jean S; Richer L; Laberge L; Mathieu J
Orphanet J Rare Dis; 2014 Nov; 9():186. PubMed ID: 25424323
[TBL] [Abstract][Full Text] [Related]
12. Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1.
Boentert M; Cao M; Mass D; De Mattia E; Falcier E; Goncalves M; Holland V; Katz SL; Orlikowski D; Sannicolò G; Wijkstra P; Hellerstein L; Sansone VA
Respiration; 2020; 99(4):360-368. PubMed ID: 32299079
[TBL] [Abstract][Full Text] [Related]
13. Accomplishment of instrumental activities of daily living and its relationship with cognitive functions in adults with myotonic dystrophy type 1 childhood phenotype: an exploratory study.
Tremblay M; Muslemani S; Côté I; Gagnon C; Fortin J; Gallais B
BMC Psychol; 2021 Apr; 9(1):56. PubMed ID: 33865455
[TBL] [Abstract][Full Text] [Related]
14. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.
Voermans NC; van der Bilt RC; IJspeert J; Hogrel JY; Jeanpierre M; Behin A; Laforet P; Stojkovic T; van Engelen BG; Padberg GW; Sacconi S; Lemmers RJLF; van der Maarel SM; Eymard B; Bassez G
J Neurol; 2019 Dec; 266(12):2987-2996. PubMed ID: 31471688
[TBL] [Abstract][Full Text] [Related]
15. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.
Hardin BA; Lowe MR; Bhakta D; Groh WJ
Ann Noninvasive Electrocardiol; 2003 Jul; 8(3):227-32. PubMed ID: 14510658
[TBL] [Abstract][Full Text] [Related]
16. Urinary titin in myotonic dystrophy type 1.
Varga D; Perecz B; Fülöp K; Sipos A; Janszky JV; Hajdú N; Pál E
Muscle Nerve; 2023 Aug; 68(2):215-218. PubMed ID: 37291994
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
[TBL] [Abstract][Full Text] [Related]
18. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
[TBL] [Abstract][Full Text] [Related]
19. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ).
Hermans MC; Faber CG; De Baets MH; de Die-Smulders CE; Merkies IS
Neuromuscul Disord; 2010 May; 20(5):310-8. PubMed ID: 20363134
[TBL] [Abstract][Full Text] [Related]
20. Daily activity performance in congenital and childhood forms of myotonic dystrophy type 1: a population-based study.
Eriksson BM; Ekström AB; Peny-Dahlstrand M
Dev Med Child Neurol; 2020 Jun; 62(6):723-728. PubMed ID: 31701525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
